vishwa parekh

Dr. vishwa parekh

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2017 in npj Breast Cancer
Verified
Journal Article
Open access
PDF file
VPvishwa parekh
vishwa parekh
MJMichael A Jacobs
Michael A Jacobs
Radiomics deals with the high throughput extraction of quantitative textural information from radiological images that not visually perceivable by radiologists. However, the biological correlation between radiomic features and different tissues of interest has not been established. To that end, we present the radiomic feature mapping framework to generate radiomic MRI texture image representations called the radiomic feature maps (RFM) and correlate the RFMs with quantitative texture values, breast tissue biology using quantitative MRI and classify benign from malignant tumors. We tested our radiomic feature mapping framework on a retrospective cohort of 124 patients (26 benign and 98 malignant) who underwent multiparametric breast MR imaging at 3 T. The MRI parameters used were T1-weighted imaging, T2-weighted imaging, dynamic contrast enhanced MRI (DCE-MRI) and diffusion weighted imaging (DWI). The RFMs were computed by convolving MRI images with statistical filters based on first order statistics and gray level co-occurrence matrix features. Malignant lesions demonstrated significantly higher entropy on both post contrast DCE-MRI (Benign-DCE entropy: 5.72 ± 0.12, Malignant-DCE entropy: 6.29 ± 0.06, p = 0.0002) and apparent diffusion coefficient (ADC) maps as compared to benign lesions (Benign-ADC entropy: 5.65 ± 0.15, Malignant ADC entropy: 6.20 ± 0.07, p = 0.002). There was no significant difference between glandular tissue entropy values in the two groups. Furthermore, the RFMs from DCE-MRI and DWI demonstrated significantly different RFM curves for benign and malignant lesions indicating their correlation to tumor vascular and cellular heterogeneity respectively. There were significant differences in the quantitative MRI metrics of ADC and perfusion. The multiview IsoSVM model classified benign and malignant breast tumors with sensitivity and specificity of 93 and 85%, respectively, with an AUC of 0.91.

1 January 2025 in Radiology
Verified
Journal Article
Closed access
CSCody H. Savage
Cody H. Savage
AKAdway Kanhere
Adway Kanhere
VPvishwa parekh
vishwa parekh
CLCurtis P. Langlotz
Curtis P. Langlotz
AJAnupam Joshi
Anupam Joshi
FDFlorence X. Doo
Florence X. Doo
Open-source large language models and multimodal foundation models offer several practical advantages for clinical and research objectives in radiology over their proprietary counterparts but require further validation before widespread adoption.


9 December 2023 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
FDFlorence X. Doo
Florence X. Doo
PKPranav Kulkarni
Pranav Kulkarni
ESEliot L. Siegel
Eliot L. Siegel
MTMichael Toland
Michael Toland
PYPaul Hyunsoo Yi
Paul Hyunsoo Yi
VPvishwa parekh
vishwa parekh

17 July 2023 in Journal of the American College of Radiology
Verified
Journal Article
Closed access
FDFlorence X. Doo
Florence X. Doo
TCTessa S. Cook
Tessa S. Cook
ESEliot L. Siegel
Eliot L. Siegel
AJAnupam Joshi
Anupam Joshi
VPvishwa parekh
vishwa parekh
PYPaul Hyunsoo Yi
Paul Hyunsoo Yi

27 September 2020 in Cancers
Verified
Journal Article
Open access
PDF file
MJMichael A Jacobs
Michael A Jacobs
CUChristopher Umbricht
Christopher Umbricht
VPvishwa parekh
vishwa parekh
RKRiham H. El Khouli
Riham H. El Khouli
LCLeslie Cope
Leslie Cope
AWAntonio C. Wolff
Antonio C. Wolff
Optimal use of multiparametric magnetic resonance imaging (mpMRI) can identify key MRI parameters and provide unique tissue signatures defining phenotypes of breast cancer. We have developed and implemented a new machine-learning informatic system, termed Informatics Radiomics Integration System (IRIS) that integrates clinical variables, derived from imaging and electronic medical health records (EHR) with multiparametric radiomics (mpRad) for identifying potential risk of local or systemic recurrence in breast cancer patients. We tested the model in patients (n = 80) who had Estrogen Receptor positive disease and underwent OncotypeDX gene testing, radiomic analysis, and breast mpMRI. The IRIS method was trained using the mpMRI, clinical, pathologic, and radiomic descriptors for prediction of the OncotypeDX risk score. The trained mpRad IRIS model had a 95% and specificity was 83% with an Area Under the Curve (AUC) of 0.89 for classifying low risk patients from the intermediate and high-risk groups. The lesion size was larger for the high-risk group (2.9 ± 1.7 mm) and lower for both low risk (1.9 ± 1.3 mm) and intermediate risk (1.7 ± 1.4 mm) groups. The lesion apparent diffusion coefficient (ADC) map values for high- and intermediate-risk groups were significantly (p < 0.05) lower than the low-risk group (1.14 vs. 1.49 × 10−3 mm2/s). These initial studies provide deeper insight into the clinical, pathological, quantitative imaging, and radiomic features, and provide the foundation to relate these features to the assessment of treatment response for improved personalized medicine.